Tag Archives: ATT

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine

Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine

VICTORIA, British Columbia, Nov. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced today that it has completed its previously announced investment of $2.5 million into Northern Vine Canada Inc. (“Northern Vine”) to acquire 53% of the company and appoint three of its four directors.

abattis bioceuticals_added_to_marijuana_index

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC

VANCOUVER, British Columbia, April 7, 2017 /Weed Wire/ — Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector.

abattis

Abattis Announces the Appointment of Dr. Shuang Xie as a Director and Provides Progress Report on Initiatives in China

VANCOUVER, British Columbia, Nov. 14, 2016 /Weed Wire/ — Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis”), is pleased to announce the appointment of Dr. Shuang Xie to the Board of Directors. Dr. Xie recently joined Abattis as the Chief Technology Advisor and continues in that capacity.


Top